Latest Patent Grants News

Avecho Biotechnology has received patent allowances in the US and Europe for its proprietary CBD soft-gel formulation, reinforcing its intellectual property ahead of pivotal Phase III insomnia trial results expected in mid-2026.

Everest Metals Corporation has reported impressive rubidium assay results up to 0.79% Rb₂O from its Phase 2 drilling at the Mt Edon Critical Mineral Project, reinforcing the potential for resource expansion ahead of a planned upgrade in early 2026.

Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.

Recce Pharmaceuticals has secured a key patent in Hong Kong for its synthetic anti-infectives, reinforcing its intellectual property footprint in Asia and supporting its clinical and commercial ambitions in the region.

Livium Ltd has been granted a patent protecting its innovative wet shredding process for lithium-ion battery recycling, enhancing safety and operational efficiency. This milestone solidifies its position in the evolving clean energy recycling sector.

EcoGraf Limited advances key milestones in its vertically integrated battery anode materials business, including nearing completion of debt financing for the Epanko Graphite Project and securing a pivotal HFfree purification patent.

Firebird Metals has advanced its manganese-rich battery materials strategy with new Chinese patents, a significant kiln sales interest, and a A$6 million capital raise, alongside key leadership changes.

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.

Talga Group has made significant strides in Q1 FY2026 with key partnerships in the US and Germany, new patents, and a substantial Swedish government grant to advance its battery anode production.

Sparc Technologies has completed construction of a pioneering green hydrogen pilot plant and secured new patents, while its graphene additive trials show promising corrosion resistance results.

Immutep Limited reports strong progress in its Phase III lung cancer trial with over 170 patients enrolled, alongside positive FDA feedback and a robust cash position supporting ongoing development.

Noxopharm Limited has been granted its first US patent for the Sofra™ technology platform, marking a key milestone in its cancer immunotherapy research. This patent protects the company’s innovative immune-modulatory oligonucleotides, underpinning its expanding pipeline in a rapidly growing market.